Cargando…

Hyperuricemia Is Not Predictive of Long-Term Outcome in Patients with Stable Chronic Obstructive Pulmonary Disease

BACKGROUND: Although the association of hyperuricemia with an increased risk of mortality has been demonstrated in the context of acute exacerbation of chronic obstructive pulmonary disease (COPD), the long-term outcomes of hyperuricemia have not been studied in the case of stable COPD. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hwang, Jae-Joon, Oh, Yeon-Mok, Rhee, Chin Kook, Yoo, Kwang Ha, Park, Yong Bum, Yoon, Ho Il, Lim, Seong Yong, Lee, Ji-Hyun, Kim, Eun-Kyung, Kim, Tae-Hyung, Lee, Sei Won, Lee, Sang-Do, Lee, Jae Seung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Academy of Medical Sciences 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7049621/ https://www.ncbi.nlm.nih.gov/pubmed/32103646 http://dx.doi.org/10.3346/jkms.2020.35.e58

Ejemplares similares

Impact of Previous Occupational Exposure on Outcomes of Chronic Obstructive Pulmonary Disease
por: Kim, Youlim, et al.
Publicado: (2022)

Three-month Treatment Response and Exacerbation in Chronic Obstructive Pulmonary Disease
por: Lee, Jung Su, et al.
Publicado: (2015)

Implications of Emphysema and Lung Function for the Development of Pneumonia in Patients with Chronic Obstructive Pulmonary Disease
por: Hong, Yoonki, et al.
Publicado: (2016)

Definitions of Chronic Obstructive Pulmonary Disease and Chronic Obstructive Pulmonary Disease Exacerbation: A Modified Delphi Survey
por: Park, Yong Bum, et al.
Publicado: (2023)

Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study
por: Kim, Jinhee, et al.
Publicado: (2013)

Influence of Environmental Exposures on Patients with Chronic Obstructive Pulmonary Disease in Korea
por: Hong, Yoonki, et al.
Publicado: (2014)

Chronic Obstructive Pulmonary Disease Is Not Associated with a Poor Prognosis in COVID-19
por: Kim, Youlim, et al.
Publicado: (2022)

Cut-off value of FEV(1)/FEV(6) to determine airflow limitation using handheld spirometry in subjects with risk of chronic obstructive pulmonary disease
por: Hwang, Yong Il, et al.
Publicado: (2021)

The health care burden of high grade chronic obstructive pulmonary disease in Korea: analysis of the Korean Health Insurance Review and Assessment Service data
por: Kim, JinHee, et al.
Publicado: (2013)

The health-related quality-of-life of chronic obstructive pulmonary disease patients and disease-related indirect burdens
por: Choi, Hye Sook, et al.
Publicado: (2020)

High urinary desmosine is associated with long-term mortality in patients with COPD
por: Kim, Changhwan, et al.
Publicado: (2023)

Impact of BMI on exacerbation and medical care expenses in subjects with mild to moderate airflow obstruction
por: Jo, Yong Suk, et al.
Publicado: (2018)

Effect of Broncho-Vaxom (OM-85) on the frequency of chronic obstructive pulmonary disease (COPD) exacerbations
por: Choi, Joon Young, et al.
Publicado: (2023)

The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease
por: Shin, Tae Rim, et al.
Publicado: (2015)

Direct and Indirect Costs of Chronic Obstructive Pulmonary Disease in Korea
por: Kim, Changhwan, et al.
Publicado: (2019)

Recent Prevalence of and Factors Associated With Chronic Obstructive Pulmonary Disease in a Rapidly Aging Society: Korea National Health and Nutrition Examination Survey 2015–2019
por: Kim, Sang Hyuk, et al.
Publicado: (2023)

Escalation Time to Open Triple Combination Therapy from the Initiation of LAMA versus ICS/LABA in COPD Management: Findings from Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea (CITRUS) Study
por: Lee, Ye Jin, et al.
Publicado: (2021)

Metabolic Syndrome in Early Chronic Obstructive Pulmonary Disease: Gender Differences and Impact on Exacerbation and Medical Costs
por: Choi, Hye Sook, et al.
Publicado: (2019)

Risk factors for early readmission after acute exacerbation of chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2020)

Mixed Phenotype of Emphysema and Airway Wall Thickening Is Associated with Frequent Exacerbation in Chronic Obstructive Pulmonary Disease Patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Strategies for Management of the Early Chronic Obstructive Lung Disease
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Prescription Status and Clinical Outcomes of Methylxanthines and Leukotriene Receptor Antagonists in Mild-to-Moderate Chronic Obstructive Pulmonary Disease
por: Lee, Jung-Kyu, et al.
Publicado: (2019)

Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Characteristics of Patients with Chronic Obstructive Pulmonary Disease at the First Visit to a Pulmonary Medical Center in Korea: The KOrea COpd Subgroup Study Team Cohort
por: Lee, Jung Yeon, et al.
Publicado: (2016)

Comparison of Korean COPD Guideline and GOLD Initiative Report in Term of Acute Exacerbation: A Validation Study for Korean COPD Guideline
por: Hwang, Yong Il, et al.
Publicado: (2014)

Different Pattern of Chronic Obstructive Pulmonary Disease Assessment Test Score between Chronic Bronchitis and Non-chronic Bronchitis Patients
por: Yoo, Sang Hoon, et al.
Publicado: (2018)

Summary of the Chronic Obstructive Pulmonary Disease Clinical Practice Guideline Revised in 2014 by the Korean Academy of Tuberculosis and Respiratory Disease
por: Yoon, Hyoung Kyu, et al.
Publicado: (2017)

Revised (2018) COPD Clinical Practice Guideline of the Korean Academy of Tuberculosis and Respiratory Disease: A Summary
por: Park, Yong-Bum, et al.
Publicado: (2018)

Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD
por: Lee, Eung Gu, et al.
Publicado: (2023)

Prevalence, characteristics, and risk of exacerbation in young patients with chronic obstructive pulmonary disease
por: Jo, Yong Suk, et al.
Publicado: (2022)

Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma–COPD overlap syndrome
por: Lee, Suh-Young, et al.
Publicado: (2016)

Factors associated with plasma IL-33 levels in patients with chronic obstructive pulmonary disease
por: Kim, Sei Won, et al.
Publicado: (2017)

Heterogeneity of asthma–chronic obstructive pulmonary disease (COPD) overlap from a cohort of patients with severe asthma and COPD
por: Choi, Joon Young, et al.
Publicado: (2023)

Active case finding strategy for chronic obstructive pulmonary disease with handheld spirometry
por: Kim, Joo Kyung, et al.
Publicado: (2016)

Racial Differences in Prevalence and Clinical Characteristics of Asthma–Chronic Obstructive Pulmonary Disease Overlap
por: Jo, Yong Suk, et al.
Publicado: (2021)

Ambulatory oxygen therapy with documented self-monitoring of oxygen use improves health status among patients with chronic obstructive pulmonary disease
por: Kim, Youlim, et al.
Publicado: (2022)

Risk of Rapid Lung Function Decline in Young Adults With Chronic Obstructive Pulmonary Disease: A Community-Based Prospective Cohort Study
por: Kim, Sang Hyuk, et al.
Publicado: (2022)

Visual and Quantitative Assessments of Regional Xenon-Ventilation Using Dual-Energy CT in Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Comparison with Chronic Obstructive Pulmonary Disease
por: Hwang, Hye Jeon, et al.
Publicado: (2020)

Blood eosinophil count as a prognostic biomarker in COPD
por: Oh, Yeon-Mok, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7gkbr1bvs3lq8jb8k5toqemtp9